JPMorgan Chase: Anatomy Of A Winner

Summary:

  • JPMorgan Chase reaffirmed its ROTCE target of ~17% and CET1 target of ~13.5% while increasing its 2023 NII outlook due to the First Republic Bank acquisition.
  • The bank showcased its ‘universal banking model’ with leading positions in CCB, CIB, CB, and AWM, and highlighted opportunities for further growth across its business segments.
  • Despite challenges in investment banking and credit, JPMorgan’s strong business moat and attractive P/E ratio make it a good investment, with the author reiterating an Overweight/Buy rating on the stock.
JP Morgan Chase & Co. and EY offices in San Francisco

Sundry Photography/iStock Editorial via Getty Images

On Monday May 22, JPMorgan Chase & Co (NYSE:JPM) held its annual investor day in NYC and delivered more than 250 slides worth of content covering the bank’s competitive strategy, growth and profitability outlook, as well as challenges. Overall, the key


Analyst’s Disclosure: I/we have a beneficial long position in the shares of JPM either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Not financial advice.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.


Leave a Reply

Your email address will not be published. Required fields are marked *